1. P635 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease. (25th January 2019) Authors: Guardiola, J; Rodriguez Alonso, L; Santacana, E; Padró, A; Serra, K; Padullés, N; Ruiz-Cerulla, A; Gilabert, P; Arajol, C; Ibañez-Sanz, G; Camps, B; Orobitg, J; Serracarbasa, A; de la Peña, L; Berrozpe, A; Rodriguez Moranta, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P645 Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients. (25th January 2019) Authors: Guardiola, J; Rodriguez Alonso, L; Padullés, N; Santacana, E; Serra, K; Padulles, A; Ruiz-Cerulla, A; Gilabert, P; Arajol, C; Ibañez-Sanz, G; Camps, B; Colom, H; Bas, J; Morandeira, F; Sanchez, E; Orobitg, J; Rodriguez Moranta, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗